Altering pH bumps prions out of danger zone

March 20, 2017 by Layne Cameron , Lisa Lapidus
Lisa Lapidus, MSU professor of physics and astronomy, has pioneered a laser technique that measures the speed at which proteins rearrange before beginning to clump, or aggregate - the critical beginning of many neurodegenerative diseases. Credit: Derrick Turner

Prion diseases are scary, incurable and fatal. They first gained notoriety when cows became infected by prion proteins and, in turn, infected people. Fervor surrounding mad cow disease resulted in the U.S. banning imports of beef from the European Union for 15 years.

New research led by Michigan State University and published in the current issue of the Proceedings of the National Academy of Sciences, offers hope by showing how we might prevent prions from aggregating or growing into deadly diseases. The results also show that an antihistamine, astemizole, proved effective in reducing aggregation.

Lisa Lapidus, MSU professor of physics and astronomy, has pioneered a laser technique to advance her medical discoveries. The two-laser approach measures the speed at which proteins rearrange before beginning to clump, or aggregate—the critical beginning of many neurodegenerative diseases.

"While prion's transmission method is quite unusual, the process of clumping is quite common in a number of diseases, such as Alzheimer's and Parkinson's disease," said Lapidus, who published the paper with Kinshuk Raj Srivastava, former postdoctoral fellow at MSU. "We've discovered that there is a 'dangerous middle range,' a speed that individual proteins rearrange in which clumping happens fastest. We were also able to find a way to bump the proteins out of the danger zone and reduce the chances of clumping from happening."

Bumping proteins out of the danger zone could help advance research on prion diseases, such as and kuru in humans, , and in deer.

What these prion diseases have in common, the team discovered, is the key speed changer of pH. Using the protein from a hamster, a mammal with a history of suffering from prion diseases, the team found that prion-related protein chains reconfigure slowly at neutral pH, thus avoiding the sticky middle speeds.

However, at low pH, the scientists found the protein rearranged in the dangerous middle range, confirming that prions thrived and grew when pH levels were low. To further prove this middle regime is really dangerous, they compared the speed of hamster at low pH to rabbit, an animal that doesn't get . Rabbit prion was much faster than hamster.

"If rearrangement is fast, when two chains come into contact, they can rearrange rapidly enough to avoid making interactions that lead to clumping," Lapidus said. "When moving slow, neither chains will have sticky patches exposed. But when the rearrangements are happening at the same speed as the random collisions between two proteins, then clumping can occur more quickly."

Taking the research one step further, Lapidus and her team decided to see if any drugs could move hamster prions out of this danger zone. Lapidus proved that astemizole is effective in speeding up protein self-interactions even further and preventing prion clumping.

Astemizole was once used to treat allergies, but it was pulled from the market due to rare but sometimes fatal side effects. The antihistamine, however, also has shown promise in some Alzheimer's research.

This research didn't directly examine disease transmission, but future research could tackle this and help understand how proteins rearranging in the danger zone can be recruited by an existing clump of protein.

While this research is years away from medical trials, it at least makes prion diseases a little less scary.

Explore further: Alzheimer's beginnings prove to be a sticky situation

More information: Prion protein dynamics before aggregation, PNAS, www.pnas.org/cgi/doi/10.1073/pnas.1620400114

Related Stories

Recommended for you

Tick protein helps antibiotics combat MRSA super bug

April 27, 2017

A protein derived from ticks enhances the effectiveness of antibiotic treatment for methicillin-resistant Staphylococcus aureus, or MRSA, according to a Yale-led study. The strategy of using the protein in combination with ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.